Clorox International Sales Jump 7% to $294M, EBIT Soars 48%
In Q2 fiscal 2026, Clorox’s International segment delivered a 7% net sales increase to $294 million and a 48% surge in adjusted EBIT, with organic sales up 5%. Shares have gained 12.6% over three months, while a 17.4x forward P/E lags the 19.03x industry average and FY26 EPS are expected to drop 23.5% year-over-year.
1. International Segment Performance
In Q2 fiscal 2026, Clorox’s International segment reported net sales of $294 million, a 7% year-over-year increase driven by favorable price mix, foreign exchange gains, and higher volumes. Organic sales rose 5%, and segment adjusted EBIT jumped 48% as cost savings combined with revenue growth improved profitability.
2. Valuation and Share Performance
Clorox shares have climbed 12.6% over the past three months, outperforming the 10.6% industry gain. The stock trades at a 17.4x forward price-to-earnings ratio, below the 19.03x industry average, while FY 2026 earnings are forecast to decline 23.5% year-over-year before rebounding in FY 2027.
3. Outlook and Risks
The company expects international segment sales to grow 5% in Q3 and 0.5% for full-year fiscal 2026, leveraging product innovation and operational efficiencies. Growth depends on navigating currency volatility, regulatory complexities, competitive pricing pressures, and supply-chain challenges in emerging markets.